Total Payments
$1,193
2024 Payments
$530.75
Companies
15
Transactions
34
Medicare Patients
5,901
Medicare Billing
$565,970
Payment Breakdown by Category
Food & Beverage$1,178 (98.7%)
Education$15.27 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,178 | 33 | 98.7% |
| Education | $15.27 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $278.65 | 7 | $0 (2024) |
| UCB, Inc. | $195.41 | 2 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $189.21 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $98.46 | 3 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $69.82 | 1 | $0 (2018) |
| Lilly USA, LLC | $65.41 | 3 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $59.01 | 3 | $0 (2020) |
| Incyte Corporation | $47.19 | 2 | $0 (2024) |
| PFIZER INC. | $40.26 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $36.09 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $530.75 | 15 | UCB, Inc. ($195.41) |
| 2023 | $140.26 | 2 | ABBVIE INC. ($124.99) |
| 2021 | $42.90 | 2 | AbbVie Inc. ($26.16) |
| 2020 | $78.72 | 4 | AbbVie Inc. ($22.32) |
| 2019 | $74.40 | 4 | Sun Pharmaceutical Industries Inc. ($23.48) |
| 2018 | $167.03 | 4 | Janssen Scientific Affairs, LLC ($69.82) |
| 2017 | $158.93 | 3 | Regeneron Healthcare Solutions, Inc. ($134.74) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.32 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/12/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $27.66 | General |
| 10/01/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.90 | General |
| Category: Dermatology | ||||||
| 09/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $36.09 | General |
| Category: Immunology | ||||||
| 08/20/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: DERMATOLOGY | ||||||
| 07/30/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: Dermatology | ||||||
| 07/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $31.15 | General |
| Category: IMMUNOLOGY | ||||||
| 06/14/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: Dermatology | ||||||
| 06/11/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Immunology | ||||||
| 05/22/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: Immunology | ||||||
| 04/30/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.29 | General |
| Category: Dermatology | ||||||
| 04/09/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: DERMATOLOGY | ||||||
| 01/08/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $166.66 | General |
| Category: Immunology | ||||||
| 04/10/2023 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 03/02/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: IMMUNOLOGY | ||||||
| 06/18/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: IMMUNOLOGY | ||||||
| 06/02/2021 | Almirall LLC | Seysara (Drug) | Food and Beverage | Cash or cash equivalent | $16.74 | General |
| Category: Dermatology | ||||||
| 12/01/2020 | AbbVie Inc. | SKYRIZI (Biological), HUMIRA | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: IMMUNOLOGY | ||||||
| 02/24/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/04/2020 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | Cash or cash equivalent | $14.95 | General |
| Category: Dermatology | ||||||
| 01/21/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2019 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Immunology | ||||||
| 04/23/2019 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | Cash or cash equivalent | $23.48 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,596 | 4,454 | $573,990 | $168,076 |
| 2022 | 15 | 1,598 | 5,012 | $560,889 | $160,569 |
| 2021 | 12 | 1,474 | 2,995 | $467,359 | $142,564 |
| 2020 | 11 | 1,233 | 2,216 | $354,415 | $94,761 |
Total Patients
5,901
Total Services
14,677
Medicare Billing
$565,970
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 249 | 330 | $120,120 | $35,743 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 341 | 429 | $105,963 | $33,482 | 31.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 170 | 206 | $73,656 | $20,737 | 28.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 257 | 322 | $67,865 | $17,671 | 26.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 59 | 80 | $41,360 | $13,474 | 32.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 75 | 91 | $25,329 | $10,595 | 41.8% |
| 95044 | Test for allergy using skin patch | Office | 2023 | 17 | 1,587 | $44,886 | $8,515 | 19.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 199 | 1,135 | $23,835 | $8,057 | 33.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 128 | 148 | $22,792 | $7,461 | 32.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 26 | $12,714 | $4,184 | 32.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 40 | 55 | $13,255 | $2,838 | 21.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 11 | 15 | $11,280 | $2,303 | 20.4% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 16 | 17 | $7,633 | $2,240 | 29.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 13 | 13 | $3,302 | $773.65 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 377 | 500 | $120,000 | $36,572 | 30.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 215 | 281 | $99,193 | $28,510 | 28.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 274 | 362 | $73,200 | $18,709 | 25.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 145 | 175 | $60,187 | $17,255 | 28.7% |
| 95044 | Test for allergy using skin patch | Office | 2022 | 24 | 2,004 | $56,112 | $10,879 | 19.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 47 | 56 | $28,392 | $9,409 | 33.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 207 | 1,281 | $26,901 | $9,106 | 33.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 59 | 69 | $18,358 | $7,318 | 39.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 123 | 143 | $21,164 | $7,286 | 34.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 21 | 24 | $16,756 | $4,181 | 25.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 33 | 33 | $14,058 | $4,168 | 29.7% |
About Dr. Renata Mullen, MD
Dr. Renata Mullen, MD is a Dermatology healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760493068.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Renata Mullen, MD has received a total of $1,193 in payments from pharmaceutical and medical device companies, with $530.75 received in 2024. These payments were reported across 34 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,178).
As a Medicare-enrolled provider, Mullen has provided services to 5,901 Medicare beneficiaries, totaling 14,677 services with total Medicare billing of $565,970. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Palo Alto, CA
- Active Since 08/11/2006
- Last Updated 03/03/2020
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1760493068
Products in Payments
- Bimzelx (Biological) $195.41
- RINVOQ (Biological) $156.14
- DUPIXENT DUPILUMAB INJECTION (Biological) $134.74
- Tremfya (Drug) $95.97
- SKYRIZI (Biological) $79.80
- COSENTYX (Biological) $70.90
- TALTZ (Drug) $65.41
- DUPIXENT (Biological) $54.47
- OPZELURA (Drug) $47.19
- Humira (Biological) $42.71
- ILUMYA (Biological) $38.43
- Sotyktu (Drug) $36.09
- XTRAC (Device) $29.28
- COSENTYX (Drug) $27.56
- EUCRISA (Drug) $24.99
- ILUMYA (tildrakizumab-asmn) injection (Biological) $20.58
- Seysara (Drug) $16.74
- CIBINQO (Drug) $15.27
- ADBRY (Biological) $13.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Palo Alto
John Doux, M.d, M.D
Dermatology — Payments: $124,944
Dermatology $124,944
Joyce Teng, Md, MD
Dermatology — Payments: $115,109
Dermatology $115,109
Shireen Guide, Md, MD
Dermatology — Payments: $79,371
Dermatology $79,371
Ilka Netravali, Md, MD
Dermatology — Payments: $28,025
Dermatology $28,025
Dr. Daniel Navi, M.d, M.D
Dermatology — Payments: $19,065
Dermatology $19,065
Dr. Thomas Hoffman, M.d, M.D
Dermatology — Payments: $17,860
Dermatology $17,860